As of April 2025 Acrivon Therapeutics has a market cap of €38.41 Million. This makes Acrivon Therapeutics the world's 9616th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Apr 7th, 2025 the market cap of Acrivon Therapeutics was reported to be: